Kris Liu
机构：Jazz Pharmaceuticals (United States)
发表论文 3 篇 · 总被引 21 次 · h-index 1
代表论文
- Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial (2021 · Movement Disorders · 被引 21)
- Safety and Efficacy of Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Parkinson’s Disease in a Four-Week Double-blind, Placebo-controlled Randomized Crossover Study (P3.8-036) (2019 · Neurology)
- 0617 Solriamfetol Treatment of Excessive Daytime Sleepiness in Parkinson’s Disease: Results from a Phase 2 Proof-of-Concept Trial (2019 · SLEEP)